Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lothar Groebe

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Plos One|December 17, 2011
Streamlining homogeneous glycoprotein production for biophysical and structural applications by targeted cell line developmentSonja Wilke, Lothar Groebe, Vitali Maffenbeier, et al.
Frontiers in Immunology|May 12, 2025
<i>In vivo</i> RNAi screen and validation reveals Ngp, Hba-a1, and S100a8 as novel inhibitory targets on T lymphocytes in liver cancerInga Hochnadel, Lisa Hoenicke, Nataliia Petriv, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Plos One|December 17, 2011
Streamlining homogeneous glycoprotein production for biophysical and structural applications by targeted cell line developmentSonja Wilke, Lothar Groebe, Vitali Maffenbeier, et al.
Frontiers in Immunology|May 12, 2025
<i>In vivo</i> RNAi screen and validation reveals Ngp, Hba-a1, and S100a8 as novel inhibitory targets on T lymphocytes in liver cancerInga Hochnadel, Lisa Hoenicke, Nataliia Petriv, et al.
Pageof 2